☆ 4.6 Meeting Abstract

Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRASG12C Inhibitor, Evaluated in NSCLC

JOURNAL OF THORACIC ONCOLOGY (2019)

Journal

JOURNAL OF THORACIC ONCOLOGY

Volume 14, Issue 10, Pages S208-S208

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.jtho.2019.08.412

Keywords

KRAS; KRAS(G12C); AMG 510

Categories

Oncology Respiratory System

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.